Brinker Capital Investments, LLC Karuna Therapeutics, Inc. Transaction History

Brinker Capital Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 31, 2025	SELL	$0.0 - $329.83 $0 - $2.26 Million	-6,848 Closed	0 $0
Q4 2023 Jul 31, 2025	SELL	$161.01 - $317.85 $49,269 - $97,262	-306 Reduced 4.28%	6,848 $2.17 Million
Q3 2023 Jul 31, 2025	SELL	$164.66 - $218.08 $170,423 - $225,712	-1,035 Reduced 12.64%	7,154 $1.21 Million
Q2 2023 Jul 31, 2025	BUY	$176.32 - $240.22 $368,685 - $502,300	2,091 Added 34.29%	8,189 $1.78 Million
Q4 2022 Feb 06, 2023	BUY	$191.53 - $236.82 $351,840 - $435,038	1,837 Added 43.11%	6,098 $1.2 Million

Q3 2022 Nov 01, 2022	BUY	$123.79 - $277.42 $527,469 - $1.18 Million	4,261 New	4,261 $958,000
Q1 2021 May 12, 2021	SELL	$95.46 - $133.08 $199,320 - $277,871	-2,088 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $157,080 - $228,072	2,088 New	2,088 $212,000

320K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.